Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

One year after mammoth lung cancer win, Merck's Keytruda holds its own in tough-to-treat subgroups

fiercepharmaApril 02, 2019

Tag: mammoth lung cancer , Merck

PharmaSources Customer Service